Investor Presentation • Nov 30, 2022
Investor Presentation
Open in ViewerOpens in native device viewer

Financial Review

This presentation does not constitute an offer to purchase the Company's securities or solicitation to receive such offers and is designed solely to offer information as part of the Company's explanations regarding its 9M 2022 financial reports.
This presentation includes information regarding the Company's strategic plan for the years 2022-25 as well as forward-looking information as defined in section 32A of the Securities Law 5728-1968.
The realization and/or non-realization of forward-looking information which is stated in the financial reports and this presentation will be affected by risk factors that characterize the activities of the Company and group companies, as detailed in the Company's periodic reports, including changes in economic conditions, capital market in Israel and globally, the development of competition in the segments relevant to the group's activities, regulatory changes, changes in consumer preferences and consumption habits, changes in working assumptions or in the economic models and assumptions, and changes in implementation or execution – that can not be estimated in advance and may not be controlled by the Company. Hence, there is no certainty that the actual results and achievements of the Company in the future will be in accordance with these views and may differ, also substantially, from those presented in this presentation.
Furthermore, the presentation includes data and assessments based on external sources, the contents of which were not independently tested by the Company and therefore the Company is not responsible for their accuracy.
This presentation was drafted for the sake of convenience and needs to be reviewed along side with the Company's public reports, including Q3 2022 Financial Statements, which contain the complete information about the Company, before making any decision to invest in the Company's securities.
This presentation may include information that is presented differently from the way it was presented in the company's official reports, some information may be presented and/or categorized and/or edited and/or segmented differently from the company's official past reports.
For the avoidance of doubt, the Company does not undertake to update or change the information contained in this presentation.



Financial Results
Segment Breakdown
Appendix
Glossary




| 4
(1) As of November 22, 2022
(2) Based on average yields over 3 years ended 30.09.2022 in the general plans: #1 out of 5 in Policies (1991-2003), #1 out of 7 in Pension, & #6 out of 11 in Provident Funds
(3) As of June 30, 2022, with transitional measures; includes dividend from Phoenix Insurance to Phoenix Holdings announced June 30, 2022
(4) Five-year period (2017-21 end of year for AUM growth, Q4 2017-Q3 2022 for ROE)

Macro trends: Continued GDP growth at 7.8% (9M growth YOY); increased inflation and interest rates
Capital Markets: volatility with declines in 2022
Continued AUM contributions despite market volatility
Innovation: Vibrant tech ecosystem, #1 startups per capital, #1 R&D investment as percent of GDP 1




Long-Term Yields (10Y) 6 Percent


1Israel Securities Authority
2Israel Central Bureau of Statistics
3 World Bank, current USD, as of August 2022
4 Bank of Israel including life insurance, pension, and provident funds
5 Bloomberg; annual inflation and 30.9.22 last twelve months
6Bloomberg; long-term yields based on Israel 10-year government bond, not CPI-linked for the last month of the period



Comprehensive Income





(*) Reclassification, for details see Appendix
Notes: Additional Core Businesses includes Pension & Provident (previously held under the insurance company), Investment Services (formerly Financial Services, primarily Excellence), Agencies, and Gama. Investments include yields and variable management fees above / below real 3%. For the convenience of the presentation, the statutory tax rate in insurance and the core fee business is used, while the difference between the actual tax and the statutory tax is recorded in Special Items respectively. ROEn is normalized for 3% real yields and special items. See Glossary for definition of Special Items.



| 9

Continued Growth Across Activities

Shareholders' Equity NISm
• Dividend policy: at least 30% of comprehensive income, distributed semi-annually
• 2022 dividends: 160 NISm in September, in addition to 421 NISm in April (from 2021 income) & buyback program
| Dividend policy: NISm |
at least 30% of comprehensive income, distributed semi-annually 2022 dividends: 160 NISm in September, in addition to 421 in April (from 2021 income) & buyback program |
5,872 | 6,446 | 6,636 | 7,970 | 9,653 | 9,611 | After dividend of 160 NISm & buyback of 56 NISm during 9M 2022 |
|
|---|---|---|---|---|---|---|---|---|---|
| 2017 | 2018 | 2019 | 2020 | 2021 | 9M 2022 | ||||
| ROE* | 16.5% | 8.3% | 10.2% | 18.5% | 26.3% | 8.4% | |||
| Analysis under dividend policy 2020-21 |
Total cash to annual income |
dividends relating | - | 120 | 480 | 380 | 621 | 160 | |
| Plus: Share buyback during calendar year |
26 | 74 | 56 | ||||||
| Total under dividend policy | 406 | 695 | 216 | ||||||
| As reflected in financial statements |
Dividend distributed in cash during calendar year |
- | 120 | 480 | - | 580 | 581 | ||
| Dividend per share | - | 0.97 | 1.87 | - | 2.31 | 1.68 |


Value Drivers
Growth Engines
Insurance
Asset Management
Distribution (Agencies & More)
Credit
Accelerated Growth
Accelerating growth while shifting mix to high-ROE, capital-efficient businesses (P&C, asset management, distribution)
1 2 3 4
Innovation & Efficiency
Deepening sustainable competitive advantage with 1 NISb investments in technology (data, digitization, products) during plan
Active Management
Optimizing group portfolio, management, structure, and synergies to unlock and create value

Deploying capital against strategic priorities, reducing volatility and ensuring long-term cashflow generation


Health: travel premiums and results improvement
Technology: including product innovation (e.g., travel app), digital transformation, and data & analytics (e.g., machine learning for underwriting and pricing)

Alternative investment offering: restructuring, expansion, and AUM growth focusing on private clients
Solvency ratio: increase to 202% as of June 2022, with transitional measures; increased minimal dividend threshold from 108% to 111% (without transitional measures); growth in excess capital




Note: Mid-term Targets based on 5-year plan 2020-25 and assuming 3% return on investments. ROE target range assumes 3-5% return on Nostro investments. Actual performance will depend on financial | 15 markets, macroeconomic growth, industry trends, company performance and other variables

yield


1 Solvency ratio with transitional measures; target range based on reduced transitional measures over time
2 Expenses as percent of gross earned premiums (P&C and Health) and AUMs (Life); expenses include general and administrative expenses, as well as other expenses; Health mid-term targets without HMO activity Note: Mid-term Targets based on 5-year plan 2020-25 and assuming 3% real return on investments

Accelerated growth across segments:




Growth, Income, & Resilience: Quality Businesses



Segment Breakdown
Appendix
Glossary



9M 2022, NISm




(*) Investment income and variable management fees above/below 3% annual real return and after offsetting the deficit in variable management fees (672NISm as of 30 September, 2022)




Additional core businesses contributed 539 NISm, more than half of 841 NISm total income before tax
in 2021

Diff
Comprehensive income before tax Q3 2022, NISm
Additional core businesses contributed 131 NISm, income before tax, driving performance for the quarter


| Difference | ||||
|---|---|---|---|---|
| Phoenix Holdings NISm |
31/12/2021 | 30/09/2021 | 30/09/2022 | 12/21-9/22 |
| Cash | 2,154 | 2,399 | 2,343 | 189 |
| Intangible Assets |
2,775 | 2,683 | 2,927 | 152 |
| Deferred acquisition costs |
2,011 | 1,938 | 2,451 | 440 |
| associates Investments in |
1,346 | 579 | 1,562 | 216 |
| property Investment other - |
1,125 | 1,084 | 1,050 | -75 |
| for of securities Credit purchase |
2,550 | 2,134 | 3,357 | 807 |
| Other Assets |
5,804 | 7,397 | 6,781 | 977 |
| Financial Other Investments |
28,698 | 27,865 | 31,470 | 2,772 |
| for yield-dependent contract Assets |
97,117 | 90,809 | 95,741 | -1,376 |
| Total Assets |
143,580 | 136,888 | 147,682 | 4,102 |
| Financial liabilities |
8,813 | 8,874 | C"15,679^ | 6,866 |
| respect of non-yield Liabilities in |
||||
| insurance contracts dependent |
||||
| and contracts investments |
25,113 | 24,694 | 25,560 | 447 |
| respect of yield Liabilities in |
||||
| dependent insurance contracts |
||||
| and contracts investments |
95,629 | 89,281 | 92,588 | -3,041 |
| Other Liabilities |
4,102 | 4,680 | 3,831 | -271 |
| equity Total |
9,923 | 9,359 | 10,024 | 101 |
| Total equity and liabilities |
143,580 | 136,888 | 147,682 | 4,102 |
| Financial Liabilities (NISm) |
|||||
|---|---|---|---|---|---|
| Bonds | |||||
| CPI | Float | Fixed | |||
| linked | interest | interest | Total | ||
| Holdings Solo' |
829 | 397 | 297 | 1,523 | |
| Insurance | |||||
| Tier 1 capital |
208 | 208 | |||
| Tier 2 capital |
426 | 490 | 2,753 | 3,669 | |
| Tier capital 3 |
398 | 398 | |||
| Insurance Core Business |
634 | 490 | 3,151 | 4,275 | |
| Credit (Gama) |
1,117 | 220 | 1,337 | ||
| (AM) Investment Services |
222 | 222 | |||
| Additional Core Business |
- | 1,339 | 220 | 1,559 | |
| Total and loans bonds |
1,463 | 2,226 | 3,668 | 7,357 | |
| Exposure Ratio |
20% | 30% | 50% | 100%, | |
| Derivatives & Other |
6,727 | ||||
| cards liabilities Credit (Gama) |
1,595 | ||||
| > | Total | 15,679 |
• Increase in liabilities YTD primarily due to ongoing use of derivatives opposite relevant financial assets for operational purposes (e.g., Insurance, Excellence) and growth of Gama financing for credit portfolio and improved capital structure
• Limited leverage and financial debt at Holding Company level (1.5 NISb, primarily fixed rate / not CPI linked), mostly opposite holdings of Tier 1 capital from Phoenix Insurance
* Mainly offset against Insurance Tier 1 capital
** For more details see Q3 2022 Financial Reports (Note 5)



Financial Results
Appendix
Glossary



| Underwriting Profit | H1 | Q3 | 9M 2022 |
|---|---|---|---|
| Compulsory Motor | 44 | 26 | 70 |
| Motor Property | (96) | (32) | (128) |
| Property & Other | 68 | 35 | 103 |
| Liability | 61 | 13 | 74 |
| Total | 77 | 42 | 119 |


Liability
Compulsory motor Motor property Property and others

Note: The underwriting profit assume a real rate of return of 3%, investment income includes income from corporate account (Nostro) above or below a 3% real return (*) Reclassification, for details see Appendix
(*)
(*)



(*) Reclassification, for details see Appendix
Note: The underwriting profit assume a real rate of return of 3%, investment income includes income from own (Nostro) investments above or below a 3% real return. LAT interest - Including all changes in interest rate and excess non-marketable assets in LAT only
(*)
(*)



| 39 | |||||||
|---|---|---|---|---|---|---|---|
| 216 | (249) | 490 | 496 | ||||
| Underwriting | Special items 1-9/22 |
||||||
| 1-9/2021 | 78 | 592 | 68 | 128 | 866 | ||
| Diff | 138 | (841) | 422 | (89) | (370) | ||
| Q3/2022 | 60 | (90) | 93 | (45) | 18 | ||
| Q3/2021 | 34 | 86 | 84 | 0 | 204 | ||
| Diff | 26 | (176) | 9 | (45) | (186) |



324 (958) Financial Margin Special Items 1-9/22 (1,282) Investments above 3% • Negative impact of financial markets • Financial margin increase due to CPI index changes compared to 2021 1-9/2021 137 15 (45) 107 Diff 187 (1,297) 45 (1,065) Q3/2022 91 (293) - (202) Q3/2021 47 (14) (45) (12) Diff 44 (279) 45 (190)



| (20) | 14 | ||||
|---|---|---|---|---|---|
| 79 | 73 | ||||
| Profit from Operations |
Investments | Special Items | 1-9/22 | ||
| 1-9/2021 | 50 | 8 | (15) | 43 | |
| Diff | 29 | (28) | 29 | 30 | |
| Q3/2022 | 26 | (12) | 0 | 14 | |
| Q3/2021 | 23 | 1 | (10) | 14 | |
| Diff | 3 | (13) | 10 | 0 |


demonstrating growth in platform capabilities and AUMs of private-client alternative investments; special items include control of Phoenix Capital with one-time profit of 86 NISm
Comprehensive Income Before Tax NISm





Credit Portfolio (without credit cards) NISm

NISm bonds
last year
• Significantly improved profit from operations
growth alongside responsible policy management
• Continued growth in Gama across activities, including SME credit portfolio
• Gama capital optimization to support future growth, including 119 NISm rights and 500
• Decrease in in overall income compared to 2021 due to special item (control acquisition)
• Continued investment in organization and infrastructure to support growth while achieving

Transaction Volume
Comprehensive Income Before Tax NISm
| 48 | 48 | |||||||
|---|---|---|---|---|---|---|---|---|
| Profit from Operations |
Special items | 1-9/22 | ||||||
| 1-9/2021 | 27 220 |
247 | ||||||
| Diff | 21 (220) |
(199) | ||||||
| Q3/2022 Q3/2021 |
24 11 |
- - |
24 11 |
|||||
| Diff | 13 | - | 13 | |||||
Life Investment Other Services Other Equity Pension Provident P&C Health Agencies Credit
| 33


| 28 | (23) | |||||
|---|---|---|---|---|---|---|
| 5 | ||||||
| Financial Margin |
Subsidiaries | Other | Special Items | 1-9/22 | ||
| 1-9/2021 | 13 | (2) | (10) | 45 | 46 | |
| Diff | 15 | 2 | (13) | (45) | (41) | |
| Q3/2022 | 8 | 0 | (14) | 0 | (6) | |
| Q3/2021 | 2 | 0 | (2) | 45 | 45 | |
| Diff | 6 | 0 | (12) | (45) | (51) |



Financial Results
Segment Breakdown
Appendix
Glossary



Returns - Insurance Nostro / Corporate Account Percent (nominal)

Asset Allocation - Insurance Nostro / Corporate Account Percent (Q3 2022)


Below is an explanation of reclassifications effecting the Health and P&C segments:
For consistency, comparative figures were reclassified as well, below is a summary of the impact of the reclassification on 2021 income, showing the figures before and after reclassification:
| Comprehensive Income Before Tax (NISm) |
9M 2021 | Q3 2021 | 2021 | |||
|---|---|---|---|---|---|---|
| Before | After | Before | After | Before | After | |
| Health | ||||||
| Underwriting | 109 | 189 | 32 | 72 | 168 | 250 |
| Investments | 65 | (15) | 19 | (22) | 123 | 41 |
| Special Items | 63 | 63 | 113 | 114 | (152) | (152) |
| P&C | ||||||
| Underwriting | 233 | 226 | 53 | 54 | 285 | 277 |
| Interest | - | 7 | - | (1) | - | 8 |
Strong demographic & wealth trends with high compulsory savings rates & potential for greater penetration, macro resilience during 2020-22
Leading diversified financial services group with over \$100b AUM (including multi-line insurance, asset management, credit, & distribution), delivering best-in-class average 14% ROE and 18% AUM CAGR over the past 5 years
Significant share of income generated by recurring fee-based non-balance sheet businesses, with plan to unlock value of assets currently held at book value
Focus on accelerating growth in high ROE businesses, innovation and technology for competitive advantage and efficiency, active management of businesses to unlock & create value, & focused capital management / deployment
Consistent growth in shareholder equity with a Solvency ratio of 202% (with transitional measures) and 30% dividend distribution policy
6
1
2
3
4
5
Deep sector and broad functional experience at both board and management levels
| 38


Financial Results
Segment Breakdown
Appendix
Glossary



| AM | Asset Management; i.e. Excellence Nessuah |
|---|---|
| AUM | Assets Under Management; the total market value of all the investments that are managed by the Group |
| Bps | Basis Points; 1 basis points is .01% |
| CGU | Cost Generating Unit |
| CI | Comprehensive Income |
| CLR | Combined Loss Ratio |
| CO | Corporate, Other and Consolidation |
| CPI | Consumer Price Index; measures the average change of prices in an agreed upon basket of consumer goods and services over time |
| CSM | Contractual Service Margin |
| D&O | Directors and Officers Liability Insurance |
| DAC | Deferred Acquisition Cost |
| ESOP | Employee Stock Ownership Plan; workplace benefit program, that provides the employees with ownership interest in the company. |
| ETF | Exchange Traded Fund; an open end, tradable basket of securities that tracks an underling index, sector, or security type |
| Fixed-Rate Gov Bonds | A government issued bond for which the interest income payment is agreed upon and does not change |
| FX | Foreign Exchange Currency |
| Gama | Financial services and credit company owned by the Phoenix Group |
| Halman corporate funds | Israeli Electric Company (IEC) |
| Illiquidity Premium | Or Liquidity Premium; premium demanded by investors when any given security cannot be easily converted into cash for its fair market value. |
| IMF | International Monetary Fund |
| Index Linked Gov Bonds | A government issued bond for which the interest income payment is related (or linked) to the CPI |
| LAT | Liability Adequacy Test |
| Liquidity Premium | See Illiquidity Premium |
| LOB | Line of Business |
| LTC | Long Term Care insurance; typically helps pay for costs associated with long term care |
| LTS | Long Term Services; including but not limited to Life, Provident and Pension funds |
| Marketable Securities | Liquid financial assets that can be quickly converted into cash; most are trading assets |


| MF | Management Fees; wages charged by a financial manager |
|---|---|
| Moody's | A credit risk rating agency |
| MSCI | Morgan Stanley Capital International Emerging Markets Index; measures the performance in equity markets, specifically in global emerging markets |
| Mutual Fund | Open end, non-tradable basket of securities that tracks the performance of an undelaying index, sector, or security type |
| Net Inflows | The net amount of new cash, excluding the impact of investment market value; calculated by subtracting withdrawals from new deposits |
| NIS | New Israeli Shekel |
| Non-Marketable Securities | Asset group that is considered to be difficult to buy or sell due to the fact they are not traded on any major exchange; could include government issued debt securities, limited partnerships, real estate investments and more |
| Nostro | The account in which a financial institution manages its own funds |
| OPEX | Operational Expenses |
| P&C | Property and Casualty insurance |
| PH | Phoenix holdings |
| PHI | Permanent Health Insurance |
| PI | Phoenix insurance |
| PLI | Professional Liability insurance |
| Reinsurance | A balancing risk strategy; one or more insurers that share the liability |
| Revenue | All encompassing streams of income; including, but not limited to: premium, management fees, benefit contributions |
| RFR | Risk Free Rates |
| ROE | Return On Equity; calculated by dividing net income over total equity |
| SME60 | "The Rest Index"; tracks the performance of the 60 largest market value companies that are excluded from the Tel Aviv Stock Exchange |
| Special Items | Changes in profit or loss that are not part of the usual business of the Company, including changes in actuarial research, actuarial model changes, other structural changes and strategic acquisition costs in AM segment |
| Tel Bond 20 | Index that tracks the performance of the 20 largest Index Linked Corporate Bonds in terms of market value |
| Tel Bond 40 | Index that tracks the performance of the 40 largest Index Linked Corporate Bonds in terms of market value |
| Tel Bond 60 | Index that tracks the performance of the 60 largest Index linked Corporate Bonds in terms of market value |
| TLV 125 | An index that tracks the performance of the 125 largest market value companies in the Tel-Aviv Stock Exchange |
| TLV 35 | An index that tracks the performance of the 35 largest market value companies in the TLV Stock Exchange |
| TLV 90 | An index that tracks the performance of the 90 largest market value companies in the TLV stock Exchange |
| TMTP | Transitional Measures on Technical Provisions |
| Workers' Compensation Insurance | Insurance coverage for employees' injuries or sickness |
| Yield Curve | A line that plots interest rates of bonds with equal credit risk with different maturity dates in the future |

Financial Review
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.